Oxidized Lipids in Human Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Aberrant Oxidation of Biomolecules".
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 2901
Special Issue Editor
Special Issue Information
Dear Colleagues,
Oxidation of low-density lipoprotein (LDL) is considered a major risk factor for cardiovascular disease (CVD). Accumulating evidence shows that oxidized lipids and their active components, e.g., oxidized cholesteryl esters (OxCEs), implicate chronic inflammatory diseases, such as atherosclerosis. In the context of atherosclerosis, oxidized lipids are host-derived damaged-associated molecular patterns (DAMPs) which arise during the progression of atherosclerosis, and their accumulation has been found in human lesions as well as hypercholesterolemic animal models (mouse and zebrafish). However, the features of oxidized LDL and the underlying mechanisms in human diseases are still not clearly understood.
Thus, this Special Issue of Antioxidants will encourage researchers to publish your latest research papers and review articles on aspects of the role of oxidized lipids in human diseases. This research will be able to include both in vivo and in vitro studies relating to any of various concepts regarding oxidized lipids and human diseases, such as atherosclerosis and inflammatory disease. Your contribution will help toward a better understanding of the mechanism by which oxidized lipids induce human diseases and to generate the new treatments of oxidized lipid-related human diseases.
We look forward to your contribution.
Dr. Soo-Ho Choi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Oxidized lipids
- Oxidized cholesteryl esters (OxCEs)
- Oxidized low-density lipoprotein (OxLDL)
- Lipoproteins
- Inflammatory diseases
- Damaged-associated molecular patterns (DAMPs)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
